Bisphosphonates
- 1 January 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 11 (1) , 1-4
- https://doi.org/10.5435/00124635-200301000-00001
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple MyelomaJournal of Clinical Oncology, 2002
- Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral DensityNew England Journal of Medicine, 2002
- The New Bisphosphonate, Zometa®(Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to PamidronateCancer Investigation, 2002
- Can Bisphosphonates Be Given to Patients with Fractures?Journal of Bone and Mineral Research, 2001
- Bisphosphonate Therapy in Fibrous DysplasiaClinical Orthopaedics and Related Research, 2001
- Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention TrialJournal of Clinical Endocrinology & Metabolism, 2000
- Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal OsteoporosisA Randomized Controlled TrialJAMA, 1999
- A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bonePostgraduate Medical Journal, 1997
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Cyclical pamidronate infusions in postmenopausal osteoporosisMaturitas, 1996